Global Oligonucleotide synthesis Market

Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031


Report ID: SQMIG35H2107 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 67 | Figures: 75

Oligonucleotide Synthesis Market Dynamics

Oligonucleotide Synthesis Market Drivers

Increasing Demand for Synthetic Oligonucleotides in Drug Development and Diagnostics

  • The growing demand for oligonucleotides in drug development and diagnostics is a key driver of the global oligonucleotide synthesis market. PCR primers, antisense oligonucleotides, and siRNA are just a few examples of oligonucleotides that are widely used in drug development and diagnostics.

Growing Focus on Targeted Gene Therapies

  • The increasing focus on targeted gene therapies is another major driver of the global oligonucleotide synthesis market. Targeted gene therapies are designed to treat genetic mutations that cause incurable diseases, and synthetic oligonucleotides play a crucial role in this process.

Oligonucleotide Synthesis Market Restraints

High Cost of Oligonucleotide Synthesis

  • The high cost of oligonucleotide synthesis is a significant restraint for the market. Oligonucleotide synthesis is a complex process that requires specialized equipment and expertise, and this drives up the cost of manufacturing oligonucleotides.

Stringent Regulations

  • The stringent regulatory environment in the pharmaceutical industry is another significant restraint for the oligonucleotide synthesis market. Regulatory agencies such as the FDA closely monitor the development and production of oligonucleotide-based therapies, and this can lead to delays and increased costs for manufacturers.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Oligonucleotide Synthesis Market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The oligonucleotide synthesis market is highly competitive and fragmented, with a large number of players operating in the market. The oligonucleotide synthesis market is driven by strategic initiatives such as collaborations, partnerships, and mergers and acquisitions. The oligonucleotide synthesis market is expected to witness intense competition among players, with a focus on innovation, product differentiation, and expansion of geographical presence. 'Agilent Technologies, Inc. (US)', 'BioAutomation Corporation (US)', 'Biosearch Technologies, Inc. (US)', 'Biolytic Lab Performance Inc. (Canada)', 'Eurofins Genomics LLC (US)', 'General Electric Company (US)', 'GenScript Biotech Corporation (China)', 'Integrated DNA Technologies, Inc. (US)', 'Kaneka Eurogentec S.A. (Belgium)', 'LGC Limited (UK)', 'Merck KGaA (Germany)', 'Nitto Denko Avecia Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'TriLink BioTechnologies, LLC (US)', 'Twist Bioscience Corporation (US)', 'ATDBio Ltd. (UK)', 'Axil Scientific Pte Ltd. (Singapore)', 'Biogen International GmbH (Switzerland)', 'Biomer Technology LLC (US)', 'Bio-Synthesis, Inc. (US)'

The growing demand for oligonucleotides in drug development and diagnostics is a key driver of the oligonucleotide synthesis market. PCR primers, antisense oligonucleotides, and siRNA are just a few examples of oligonucleotides that are widely used in drug development and diagnostics.

Increasing Demand for Customized Oligonucleotides: There has been a growing demand for customized oligonucleotides, which are tailored to specific applications. Customized oligonucleotides are used in various applications, including research, diagnostics, and therapeutics. The growing demand for customized oligonucleotides is attributed to the increasing use of oligonucleotides in drug discovery and development, genetic testing, and personalized medicine. For instance, Integrated DNA Technologies, a leading provider of customized oligonucleotides, offers a wide range of oligonucleotides for research, diagnostics, and therapeutic applications.

North America dominated the oligonucleotide synthesis market owing to the presence of major pharmaceutical and biotech companies in the region. The high adoption of advanced genomic technologies and the availability of a skilled workforce for the development of novel therapeutics is further projected to help this region continue dominance during the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Oligonucleotide synthesis Market

Product ID: SQMIG35H2107

$5,300
BUY NOW GET FREE SAMPLE